Objective: To provide a highly efficient adenoviralvector Ad-CMV-hTGFβ1 for the study of gene therapy forreversion of the intervertebral disc degeneration.Meth
Objective:To assess the feasibility of MR-guided bone biopsies.Methods::Thirty-six consecutive patients with known or suspected benign or malignant bone lesions